A look inside the Czech Republic’s booming fertility holiday industry
By Amy Speier,
The Conversation
| 03. 17. 2016
Untitled Document
In 2008, a friend sent me a link to a Czech company called IVF Holiday. Clicking the link, I saw images of quaint European towns. These were accompanied by pictures of smiling white babies – and promises of affordable and safe rounds of in vitro fertilization (IVF).
I soon realized I’d stumbled into a new type of tourism: fertility holidays.
As a medical anthropologist, I knew I had to pursue this topic. Here was a perfect example of patients turning to medicine’s global marketplace when high prices of health care back home block access to treatments.
I subsequently conducted three years of fieldwork in the Czech Republic and North America to trace the fertility journeys of 29 American reproductive tourists. Their stories are in my forthcoming book Fertility Holidays: IVF Tourism and the Reproduction of Whiteness.
A souvenir of a different sort
IVF is an assisted reproductive technology that increases the chances of conception for women or couples suffering from infertility. It monitors and stimulates a woman’s ovulation, retrieves a woman’s eggs and fertilizes the eggs with...
Related Articles
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Gabriele Pichlhofer and Tino Plümecke, Guest Contributors
| 03.25.2026
A German translation of this interview will be published in May 2026 in the German GID MAGAZIN, which focuses on the market for reproductive technologies. For more information, visit: Gen-ethisches Netzwerk
Egg donation is currently prohibited in Germany and Switzerland, but both countries have been debating its legalization for years. In Switzerland, a legal framework is currently being developed, with a first draft expected by the end of the year. Yet the debate rarely draws on scientific evidence. Instead...
By Charles Pulliam-Moore, The Verge | 03.21.2026
Like many people, director Valerie Veatch was intrigued when OpenAI first released its Sora text-to-video generative AI model to the public in 2024. Though she didn’t fully understand the technology, she was curious about what it could do, and she...
By Ritsuko Kawai, Wired | 03.14.2026
On March 6, Japan’s Ministry of Health, Labor and Welfare officially granted conditional and time-limited marketing authorization to two regenerative medical products derived from reprogrammed iPS cells, marking exactly 20 years since the creation of mouse iPS cells.These will...